Draft:Softmining
Submission declined on 22 May 2026 by Devonian Wombat (talk). This draft's references do not show that the subject meets Wikipedia's criteria for inclusion for organizations and companies. The draft requires multiple published secondary sources that:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
 | This is a draft article. It is a work in progress open to editing by anyone. Please ensure core content policies are met before publishing it as a live Wikipedia article. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL Last edited by Citation bot (talk | contribs) 30 days ago. (Update)
Finished drafting? or |
 | A major contributor to this article appears to have a close connection with its subject. (March 2026) |
 | This article needs more citations. (March 2026) |
| Type | Private |
|---|---|
| Industry | Drug discovery, computational chemistry, biomaterials, artificial intelligence |
| Headquarters | Fisciano , Italy |
Key people | Stefano Piotto (CEO)[1] |
| Website | softmining |
SoftMining S.r.l. (also stylized as SoftMining) is an Italian company described by the University of Salerno as an AI-powered drug discovery spin-off focused on computational design of small molecules and biomedical materials.[1][2]
History
SoftMining is listed among the University of Salerno spin-offs, which describe it as developing methods and algorithms for computational drug design and biomaterials.[1] An early profile in local business press described the initiative as applying computational methods to pharmaceutical research and materials design.[3]
Activities
According to public partner profiles, SoftMining develops computational tools and AI-based methods to support research pipelines for small molecules and biomaterials, with additional applications in digital health and semantic analysis.[2]
Research projects
NEWROAD (EU4Health)
SoftMining is involved in NEWROAD (Open Platform for European Networking and Repurposing of Oncological Assets and Drugs), an EU4Health-funded project aimed at developing an EU-wide capability and open collaborative platform for systematic drug repurposing in oncology.[4][5]
REPO4EU
SoftMining is listed as a community member of REPO4EU, an EU-funded initiative focused on drug repurposing.[6]
Recognition
ECHealth (IRCAI Global Top 100, 2021)
SoftMining's ECHealth project appears in IRCAI's Global Top 100 list (2021).[7]
SM-COVID-19
During the COVID-19 pandemic, Wired Italia reported on Sm_Covid19, describing it as a contact-tracing proposal developed by SoftMining, a University of Salerno spin-off, and discussing its design and privacy implications.[8]
The Corriere della Sera Dataroom column also mentioned an app named SM_Covid19 developed by SoftMining in the context of technological tools for managing COVID-19.[9]
Publications
In 2021, the Journal of Medical Internet Research published a correlational study by authors affiliated with the University of Salerno on evaluating epidemiological risk using open contact-tracing data (e28947).[10]
See also
References
- ^ a b c "Research | Spin off (SoftMining)". Università degli Studi di Salerno. Retrieved 3 March 2026.
- ^ a b "SoftMining S.r.l. (partner profile)". SMAU. Retrieved 3 March 2026.
- ^ "SoftMining, un passo avanti verso farmaci più efficaci e sicuri". Costozero. 9 March 2018. Retrieved 3 March 2026.
- ^ "NEWROAD – Open Platform for European Networking and Repurposing of Oncological Assets and Drugs". European Commission (Public Health). Retrieved 3 March 2026.
- ^ "NEWROAD – Project website". NEWROAD. Retrieved 3 March 2026.
- ^ "SoftMining – REPO4EU community member". REPO4EU. Retrieved 3 March 2026.
- ^ "ECHealth | IRCAI Global Top 100 List (2021)". IRCAI (International Research Centre on Artificial Intelligence). Retrieved 3 March 2026.
- ^ "Abbiamo analizzato tutte le app che si possono già usare per il contact tracing del coronavirus". Wired Italia. 24 March 2020. Retrieved 3 March 2026.
- ^ Gabanelli, Milena; Savelli, Fabio (23 March 2020). "Covid-19: l'arma tecnologica per arginare il virus e gestire il dopo crisi. Come funziona". Corriere della Sera (Dataroom). Retrieved 3 March 2026.
- ^ Piotto, Stefano; Di Biasi, Luigi; Marrafino, Francesco; Concilio, Simona (2 August 2021). "Evaluating Epidemiological Risk by Using Open Contact Tracing Data: Correlational Study". Journal of Medical Internet Research. 23 (8) e28947. doi:10.2196/28947. PMC 8330631. PMID 34227997. Retrieved 3 March 2026.
External links
Category:Biotechnology companies of Italy Category:Drug discovery Category:Companies based in Campania
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
Wikipedia articles must be written neutrally in a formal, impersonal, and dispassionate way. They should not read like a blog post, advertisement, or fan page. Rewrite the draft to remove:
Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject.
If you have a conflict of interest (e.g. you are the subject, an employee, or a relative) or are being paid to edit, you must disclose this to comply with Wikipedia's Terms of Use.